Close Menu

NEW YORK (GenomeWeb) – NeoGenomics reported today that its first quarter revenues grew 51 percent year over year with clinical service revenues up also 51 percent.

For the three months ended March 21, the Ft. Myers, Florida-based company recorded revenues of $95.6 million compared to $63.4 million a year ago. It beat the consensus Wall Street estimate of $90.6 million.

Clinical service revenues grew to $86.2 million from $57.0 million, and pharma service revenues grew 45 percent to $9.4 million from $6.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.